zenodoopen
Figure 1 from: Chakuleska L, Simeonova R, Danchev N (2020) Pharmacotherapy costs and medicines reimbursement policies of osteoporosis in the Republic of Bulgaria and Republic of North Macedonia. Pharmacia 67(4): 199-207. https://doi.org/10.3897/pharmacia.67.e55835
Figure 1 Total reimbursement value for antiosteoporotic drugs, granted under the NIHF in the RBG (2015–2018).
ShareScore
28/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 4
- Access
- 16
- Reuse readiness
- 0
- Engagement
- 0